For research use only. Not for therapeutic Use.
Cagrilintide acetate（Cat No.:I042801）is a novel peptide-based compound being developed for its potential use in treating various metabolic and weight-related disorders. It is an analog of a hormone involved in regulating appetite, energy balance, and glucose metabolism. Cagrilintide acetate works by modulating specific receptors in the body, leading to reduced food intake, improved insulin sensitivity, and enhanced fat metabolism. Currently, it is being studied in clinical trials as an adjunct to other therapies for obesity and type 2 diabetes. Ongoing research aims to evaluate its efficacy, safety, and long-term benefits in metabolic disease management.
| Molecular Formula | C194H312N54O59S2.xC2H4O2 |
| Purity | ≥95% |
